Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 129

1.

Genetic testing for susceptibility to breast cancer: findings from women's focus groups.

Tessaro I, Borstelmann N, Regan K, Rimer BK, Winer E.

J Womens Health. 1997 Jun;6(3):317-27.

PMID:
9201666
2.
3.

Controlled trial of pretest education approaches to enhance informed decision-making for BRCA1 gene testing.

Lerman C, Biesecker B, Benkendorf JL, Kerner J, Gomez-Caminero A, Hughes C, Reed MM.

J Natl Cancer Inst. 1997 Jan 15;89(2):148-57.

PMID:
8998184
4.

A population-based study of Ashkenazi Jewish women's attitudes toward genetic discrimination and BRCA1/2 testing.

Lehmann LS, Weeks JC, Klar N, Garber JE.

Genet Med. 2002 Sep-Oct;4(5):346-52.

PMID:
12394347
5.
6.

Psychosocial issues following a positive result of genetic testing for BRCA1 and BRCA2 mutations: findings from a focus group and a needs-assessment survey.

Di Prospero LS, Seminsky M, Honeyford J, Doan B, Franssen E, Meschino W, Chart P, Warner E.

CMAJ. 2001 Apr 3;164(7):1005-9.

7.

Perceptions of Ashkenazi Jewish breast cancer patients on genetic testing for mutations in BRCA1 and BRCA2.

Phillips KA, Warner E, Meschino WS, Hunter J, Abdolell M, Glendon G, Andrulis IL, Goodwin PJ.

Clin Genet. 2000 May;57(5):376-83.

PMID:
10852372
8.

Patients' attitudes about autonomy and confidentiality in genetic testing for breast-ovarian cancer susceptibility.

Benkendorf JL, Reutenauer JE, Hughes CA, Eads N, Willison J, Powers M, Lerman C.

Am J Med Genet. 1997 Dec 19;73(3):296-303.

PMID:
9415688
9.

Differences between women who pursued genetic testing for hereditary breast and ovarian cancer and their at-risk relatives who did not.

Katapodi MC, Northouse L, Pierce P, Milliron KJ, Liu G, Merajver SD.

Oncol Nurs Forum. 2011 Sep;38(5):572-81. doi: 10.1188/11.ONF.572-581.

PMID:
21875844
10.
11.

Individual and family characteristics associated with BRCA1/2 genetic testing in high-risk families.

Katapodi MC, Northouse LL, Milliron KJ, Liu G, Merajver SD.

Psychooncology. 2013 Jun;22(6):1336-43. doi: 10.1002/pon.3139. Epub 2012 Jul 24.

12.

Decision-making about genetic testing among women at familial risk for breast cancer.

Jacobsen PB, Valdimarsdottier HB, Brown KL, Offit K.

Psychosom Med. 1997 Sep-Oct;59(5):459-66.

PMID:
9316177
13.

Psychosocial predictors of BRCA counseling and testing decisions among urban African-American women.

Thompson HS, Valdimarsdottir HB, Duteau-Buck C, Guevarra J, Bovbjerg DH, Richmond-Avellaneda C, Amarel D, Godfrey D, Brown K, Offit K.

Cancer Epidemiol Biomarkers Prev. 2002 Dec;11(12):1579-85.

14.

"Decoding" informed consent. Insights from women regarding breast cancer susceptibility testing.

Geller G, Strauss M, Bernhardt BA, Holtzman NA.

Hastings Cent Rep. 1997 Mar-Apr;27(2):28-33.

PMID:
9131350
15.

Accommodating risk: responses to BRCA1/2 genetic testing of women who have had cancer.

Hallowell N, Foster C, Eeles R, Ardern-Jones A, Watson M.

Soc Sci Med. 2004 Aug;59(3):553-65.

PMID:
15144764
16.
17.

Fertility intentions following testing for a BRCA1 gene mutation.

Smith KR, Ellington L, Chan AY, Croyle RT, Botkin JR.

Cancer Epidemiol Biomarkers Prev. 2004 May;13(5):733-40.

18.
19.

Psychological and social determinants of women's decisions to undergo genetic counseling and testing for breast cancer.

Cappelli M, Surh L, Humphreys L, Verma S, Logan D, Hunter A, Allanson J.

Clin Genet. 1999 Jun;55(6):419-30.

PMID:
10450858
20.

Women's decision-making about their health care: views over the life cycle.

Brown JB, Carroll J, Boon H, Marmoreo J.

Patient Educ Couns. 2002 Dec;48(3):225-31.

PMID:
12477607

Supplemental Content

Support Center